One-Pot Synthesis of Benzothiazine-4-one Derivatives
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing 2-amino-substituted 1,3-benzothiazine-4-ones, such as 2-(homo)piperazine-1,3-benzothiazine-4-one derivatives, face challenges with low yields and purity issues, making them unsuitable for industrial-scale production and effective treatment of drug-resistant tuberculosis and other mycobacterial infections.
Innovation Solution
A one-pot synthesis process involving the reaction of 2-chloro-5-(trifluoromethyl)benzoyl chloride with a thiocyanate salt, followed by reaction with a piperazine or homopiperazine, and subsequent acidification with hydrochloric acid, which significantly improves yield and purity to 58%-78%.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current synthesis methods (reacting 2-chlorobenzcarboxamide with substituted piperazine sodium dithiocarbamate or metal alkylxantogenate) are used, then the process can be performed, but the yield is low and purity is compromised due to side products and multi-step isolation requirements
Solution Approach 1:
The patent combines multiple reaction steps into a single one-pot synthesis process. The reaction of 2-chlorobenzoyl chloride with thiocyanate salt to form isothiocyanate intermediate, followed by reaction with substituted piperazine or homopiperazine, occurs sequentially in the same reaction vessel without isolation of intermediates. This merging of steps eliminates contamination from isolation processes and maximizes overall yield while maintaining high purity (58%-78%).
Solution Approach 2:
The patent uses isothiocyanate as a reactive intermediary species that forms in situ from the reaction of 2-chlorobenzoyl chloride with thiocyanate salt. This intermediary then reacts with the substituted piperazine or homopiperazine to form the final benzothiazine-4-one product. The use of this intermediary mechanism enables the one-pot synthesis to proceed efficiently with high yield and purity.
2Ease of manufacture
If current synthesis methods are used, then the reaction can proceed, but the process complexity increases due to multi-step reactions requiring isolation of intermediates
Solution Approach 1:
The patent merges the formation of isothiocyanate intermediate and its subsequent reaction with substituted piperazine/homopiperazine into a single integrated reaction process. Both transformations occur in one reaction vessel without intermediate isolation, simplifying the manufacturing process to a single operational step while maintaining chemical efficiency.
Solution Approach 2:
The patent implements continuous useful action by having the isothiocyanate intermediate react immediately with the substituted piperazine or homopiperazine without interruption or isolation. The reaction sequence proceeds continuously in one pot, eliminating downtime and additional processing steps, thereby simplifying the overall manufacturing process.
3Reliability
If new drugs with novel mode of action are developed, then effectiveness against drug-resistant tuberculosis improves, but the synthesis yield remains below 1% making industrial application unsuitable
Solution Approach 1:
The patent changes the reaction parameters by using 2-chlorobenzoyl chloride combined with thiocyanate salts and substituted piperazines or homopiperazines under optimized conditions. This parameter change transforms the synthesis from a low-yield process (<1%) to a high-yield process (58%-78%), making the production of effective anti-tuberculosis drugs with novel mode of action economically viable for industrial application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process yields 2-(homo)piperazine-1,3-benzothiazine-4-one hydrochlorides with high purity and yield, demonstrating strong antibacterial activity against mycobacteria, including drug-resistant strains, with minimal inhibitory concentrations effective for treating tuberculosis, Buruli ulcer, and leprosy.
Implementation Method 1
reacting a substituted 2-chloro-5-(trifluoromethyl)benzoyl chloride with a thiocyanate salt
Implementation Method 2
reacting the resulting substituted 2-chloro-5-(trifluoromethyl)benzoyl isothiocyanate without isolation with a substituted piperazine or homopiperazine
Implementation Method 3
acidification with hydrochloric acid
Data Source
AI summary
2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives of formula (I) are provided. They are useful in the treatment of bacterial infections, in particular tuberculosis, buruli ulcer and leprosy.